Top Human Secrets
123). It can be notable that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for lack of Gls in MYC-induced mouse liver tumours40. This implies that GLS2 could confer resistance to GLS1-precise inhibitors, such as the allosteric inhibitor BPTES or CB-839, which resistance could be hypothetically averted by the usage of